|
OMIM |
Link |
Information gain |
01 |
|
CELIAC5
|
[NCBI]
|
0.00115558
|
|
|
hypoadrenocorticism, familial
|
[NCBI]
|
0.00105558
|
|
|
APS2
|
[NCBI]
|
0.000872084
|
|
|
behcet syndrome
|
[NCBI]
|
0.000550055
|
|
|
HFE
|
[NCBI]
|
0.0004887
|
|
|
MAFD1
|
[NCBI]
|
0.000395761
|
|
|
HLA-A
|
[NCBI]
|
0.000361301
|
|
|
IDDM
|
[NCBI]
|
0.000327956
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000245002
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
0.000211485
|
|
|
MICA
|
[NCBI]
|
0.000203235
|
|
|
HLA-F
|
[NCBI]
|
0.000198782
|
|
|
PPP1R11
|
[NCBI]
|
0.00016398
|
|
|
pancreatic beta cell agenesis with neonatal diabetes mellitus
|
[NCBI]
|
0.000147592
|
|
|
MAPTL
|
[NCBI]
|
0.000147592
|
|
|
HLA-B
|
[NCBI]
|
0.000139316
|
|
|
CD
|
[NCBI]
|
0.000124934
|
|
|
HLA-G
|
[NCBI]
|
0.000116861
|
|
|
CSCI
|
[NCBI]
|
0.000109361
|
|
|
TAPBP
|
[NCBI]
|
0.000102608
|
|
|
hemochromatosis, neonatal
|
[NCBI]
|
9.01519e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
8.72925e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
8.2576e-05
|
|
|
ZNRD1
|
[NCBI]
|
7.79835e-05
|
|
|
MR1
|
[NCBI]
|
7.79835e-05
|
|
|
BAT3
|
[NCBI]
|
7.28521e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
6.54569e-05
|
|
|
LST1
|
[NCBI]
|
6.44416e-05
|
|
|
MICB
|
[NCBI]
|
6.25958e-05
|
|
|
IFNGR2
|
[NCBI]
|
6.25958e-05
|
|
|
SPDA1
|
[NCBI]
|
6.14986e-05
|
|
|
BTN1A1
|
[NCBI]
|
6.10006e-05
|
|
|
gastric cancer
|
[NCBI]
|
5.88277e-05
|
|
|
HLA-C
|
[NCBI]
|
5.52205e-05
|
|
|
CDSN
|
[NCBI]
|
4.79526e-05
|
|
|
GNL1
|
[NCBI]
|
4.46481e-05
|
|
|
BAT4
|
[NCBI]
|
4.46481e-05
|
|
|
TRIM39
|
[NCBI]
|
4.46481e-05
|
|
|
TRIM26
|
[NCBI]
|
4.46481e-05
|
|
|
methylation modifier for class i hla
|
[NCBI]
|
4.46481e-05
|
|
|
BAT5
|
[NCBI]
|
4.46481e-05
|
|
|
RAET1L
|
[NCBI]
|
4.46481e-05
|
|
|
wilson disease
|
[NCBI]
|
4.06432e-05
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
4.00275e-05
|
|
|
SCA1
|
[NCBI]
|
3.76063e-05
|
|
|
SLE
|
[NCBI]
|
3.72152e-05
|
|
|
BAT2
|
[NCBI]
|
3.64037e-05
|
|
|
HLA8
|
[NCBI]
|
3.64037e-05
|
|
|
TRN
|
[NCBI]
|
3.64037e-05
|
|
|
RAET1G
|
[NCBI]
|
3.64037e-05
|
|
|
RNF39
|
[NCBI]
|
3.3294e-05
|
|
|
major histocompatibility complex, class i, gene p5-1
|
[NCBI]
|
3.3294e-05
|
|
|
immunoglobulin-like transcript 11
|
[NCBI]
|
3.3294e-05
|
|
|
UBD
|
[NCBI]
|
3.3294e-05
|
|
|
NLRP12
|
[NCBI]
|
3.3294e-05
|
|
|
PPP1R10
|
[NCBI]
|
3.3294e-05
|
|
|
TNF
|
[NCBI]
|
3.28925e-05
|
|
|
NT5E
|
[NCBI]
|
3.12756e-05
|
|
|
PSMB8
|
[NCBI]
|
3.12756e-05
|
|
|
PACS1
|
[NCBI]
|
3.12756e-05
|
|
|
RAET1E
|
[NCBI]
|
2.97757e-05
|
|
|
KIR2DS2
|
[NCBI]
|
2.97757e-05
|
|
|
HLA-E
|
[NCBI]
|
2.97757e-05
|
|
|
LTB
|
[NCBI]
|
2.8581e-05
|
|
|
TPP2
|
[NCBI]
|
2.7588e-05
|
|
|
RA
|
[NCBI]
|
2.73079e-05
|
|
|
FCGRT
|
[NCBI]
|
2.67385e-05
|
|
|
BAT1
|
[NCBI]
|
2.67385e-05
|
|
|
AZGP1
|
[NCBI]
|
2.59961e-05
|
|
|
CD74
|
[NCBI]
|
2.59961e-05
|
|
|
RXRB
|
[NCBI]
|
2.5337e-05
|
|
|
ICSBP1
|
[NCBI]
|
2.5337e-05
|
|
|
BMP6
|
[NCBI]
|
2.5337e-05
|
|
|
CD247
|
[NCBI]
|
2.47443e-05
|
|
|
CTSS
|
[NCBI]
|
2.47443e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
2.42567e-05
|
|
|
KIR2DL1
|
[NCBI]
|
2.4206e-05
|
|
|
BL
|
[NCBI]
|
2.39538e-05
|
|
|
INDO
|
[NCBI]
|
2.37129e-05
|
|
|
CD1D
|
[NCBI]
|
2.2836e-05
|
|
|
TAP1
|
[NCBI]
|
2.24423e-05
|
|
|
POU5F1
|
[NCBI]
|
2.24423e-05
|
|
|
adipocyte-derived leucine aminopeptidase
|
[NCBI]
|
2.24423e-05
|
|
|
IFNAR1
|
[NCBI]
|
2.02474e-05
|
|
|
TRIM27
|
[NCBI]
|
1.99919e-05
|
|
|
CVID
|
[NCBI]
|
1.98329e-05
|
|
|
ATXN1
|
[NCBI]
|
1.82748e-05
|
|
|
EGF
|
[NCBI]
|
1.77186e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.75765e-05
|
|
|
MG
|
[NCBI]
|
1.74284e-05
|
|
|
LTA
|
[NCBI]
|
1.71036e-05
|
|
|
CUTL1
|
[NCBI]
|
1.6667e-05
|
|
|
TFR2
|
[NCBI]
|
1.63935e-05
|
|
|
ARF6
|
[NCBI]
|
1.63935e-05
|
|
|
HLA-DRA
|
[NCBI]
|
1.63935e-05
|
|
|
temporal arteritis
|
[NCBI]
|
1.63827e-05
|
|
|
USF1
|
[NCBI]
|
1.61326e-05
|
|
|
DSG3
|
[NCBI]
|
1.5304e-05
|
|
|
B2M
|
[NCBI]
|
1.50881e-05
|
|
|
VEGF
|
[NCBI]
|
1.50499e-05
|
|
|
PROCR
|
[NCBI]
|
1.49832e-05
|
|
|
REN
|
[NCBI]
|
1.46798e-05
|
|
|
BSG
|
[NCBI]
|
1.26445e-05
|
|
|
HDAC1
|
[NCBI]
|
1.09656e-05
|
|
|
FMF
|
[NCBI]
|
1.04786e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
7.89495e-06
|
|
|
PEDF
|
[NCBI]
|
7.86817e-06
|
|
|
ACPP
|
[NCBI]
|
6.51271e-06
|
|
|
TG
|
[NCBI]
|
6.24038e-06
|
|
|
TP53
|
[NCBI]
|
6.06096e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
3.36264e-06
|
|
|
PCNA
|
[NCBI]
|
1.8068e-06
|
|
|
ACHE
|
[NCBI]
|
1.71799e-06
|
|
|
TH
|
[NCBI]
|
1.58906e-06
|
|
|
EPO
|
[NCBI]
|
1.02269e-06
|
|
|
PRL
|
[NCBI]
|
6.27818e-07
|
|
|
MPO
|
[NCBI]
|
2.36446e-07
|
|
|
TNFSF6
|
[NCBI]
|
2.0456e-07
|
|
|
HGF
|
[NCBI]
|
1.95142e-07
|
|
|
MBP
|
[NCBI]
|
1.2472e-07
|
|